Bilateral Chilblain-like Lesions of the Toes Characterized by Microvascular Remodeling in Adolescents During the COVID-19 Pandemic.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 06 2021
Historique:
entrez: 10 6 2021
pubmed: 11 6 2021
medline: 23 6 2021
Statut: epublish

Résumé

Chilblain-like lesions have been one of the most frequently described cutaneous manifestations during the COVID-19 pandemic. Their etiopathogenesis, including the role of SARS-CoV-2, remains elusive. To examine the association of chilblain-like lesions with SARS-CoV-2 infection. This prospective case series enrolled 17 adolescents who presented with chilblain-like lesions from April 1 to June 30, 2020, at a tertiary referral academic hospital in Italy. Macroscopic (clinical and dermoscopic) and microscopic (histopathologic) analysis contributed to a thorough understanding of the lesions. Nasopharyngeal swab, serologic testing, and in situ hybridization of the skin biopsy specimens were performed to test for SARS-CoV-2 infection. Laboratory tests explored signs of systemic inflammation or thrombophilia. Structural changes in peripheral microcirculation were investigated by capillaroscopy. Of the 17 adolescents (9 [52.9%] male; median [interquartile range] age, 13.2 [12.5-14.3] years) enrolled during the first wave of the COVID-19 pandemic, 16 (94.1%) had bilaterally localized distal erythematous or cyanotic lesions. A triad of red dots (16 [100%]), white rosettes (11 [68.8%]), and white streaks (10 [62.5%]) characterized the dermoscopic picture. Histologic analysis revealed a remodeling of the dermal blood vessels with a lobular arrangement, wall thickening, and a mild perivascular lymphocytic infiltrate. SARS-CoV-2 infection was excluded by molecular and serologic testing. In situ hybridization did not highlight the viral genome in the lesions. This study delineated the clinical, histologic, and laboratory features of chilblain-like lesions that emerged during the COVID-19 pandemic, and its findings do not support their association with SARS-CoV-2 infection. The lesions occurred in otherwise healthy adolescents, had a long but benign course to self-resolution, and were characterized by a microvascular remodeling with perivascular lymphocytic infiltrate but no other signs of vasculitis. These results suggest that chilblain-like lesions do not imply a concomitant SARS-CoV-2 infection. Ongoing studies will help clarify the etiopathogenic mechanisms.

Identifiants

pubmed: 34110396
pii: 2780866
doi: 10.1001/jamanetworkopen.2021.11369
pmc: PMC8193438
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2111369

Commentaires et corrections

Type : CommentIn

Références

J Am Acad Dermatol. 2020 Jul;83(1):280-285
pubmed: 32305439
J Eur Acad Dermatol Venereol. 2020 Jul;34(7):e291-e293
pubmed: 32330334
Euro Surveill. 2020 May;25(18):
pubmed: 32400362
J Am Acad Dermatol. 2020 Aug;83(2):667-670
pubmed: 32380219
Dermatology. 2021;237(1):1-12
pubmed: 33232965
JAMA Dermatol. 2021 Feb 1;157(2):202-206
pubmed: 33237291
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):2620-2629
pubmed: 32474947
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e346-e347
pubmed: 32330324
Dermatopathology (Basel). 2020 Jun 30;7(1):3-16
pubmed: 32608380
Br J Dermatol. 2020 Oct;183(4):784-785
pubmed: 32613638
Br J Dermatol. 2020 Feb;182(2):454-467
pubmed: 31077336
J Eur Acad Dermatol Venereol. 2018 May;32(5):735-744
pubmed: 28977697
Adv Rheumatol. 2019 Jan 22;59(1):5
pubmed: 30670098
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):e451-e452
pubmed: 32339344
JAMA Dermatol. 2020 Sep 1;156(9):998-1003
pubmed: 32584377
Clin Exp Dermatol. 2020 Aug;45(6):746-748
pubmed: 32302422
Br J Dermatol. 2020 Sep;183(3):431-442
pubmed: 32479680
J Am Acad Dermatol. 2020 Sep;83(3):965-969
pubmed: 32534082
Clin Rheumatol. 2016 Aug;35(8):1993-2001
pubmed: 27357717
N Engl J Med. 2020 Apr 23;382(17):1663-1665
pubmed: 32187458
Br J Dermatol. 2021 Jan;184(1):141-150
pubmed: 32779733
J Eur Acad Dermatol Venereol. 2020 Nov;34(11):e686-e689
pubmed: 32589293
Dermatol Online J. 2020 Dec 15;26(12):
pubmed: 33423412
JAMA. 2020 Sep 22;324(12):1133-1134
pubmed: 32960253
J Am Acad Dermatol. 2020 Sep;83(3):e241
pubmed: 32497704
JAAD Case Rep. 2020 Dec;6(12):1271-1274
pubmed: 33020736
J Am Acad Dermatol. 2020 Aug;83(2):486-492
pubmed: 32479979
Cell Host Microbe. 2020 Jun 10;27(6):883-890.e2
pubmed: 32407669
J Am Acad Dermatol. 2020 Sep;83(3):870-875
pubmed: 32502585
Pediatr Dermatol. 2020 May;37(3):406-411
pubmed: 32386460
Br J Dermatol. 2020 Oct;183(4):729-737
pubmed: 32562567
J Foot Ankle Res. 2020 Jun 23;13(1):38
pubmed: 32576291
J Cutan Pathol. 2021 Jan;48(1):47-52
pubmed: 32895985
Int J Infect Dis. 2021 Jan;102:53-55
pubmed: 33075530

Auteurs

Valentina Discepolo (V)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Andrea Catzola (A)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Luca Pierri (L)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Massimo Mascolo (M)

Department of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, Naples, Italy.

Francesca Della Casa (F)

Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, Naples, Italy.

Maria Vastarella (M)

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.

Grace Smith (G)

Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Antonio Travaglino (A)

Department of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, Naples, Italy.

Alessandra Punziano (A)

Department of Translational Medical Sciences, Section of Clinical Immunology, University of Naples Federico II, Naples, Italy.

Paola Nappa (P)

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.

Stefania Staibano (S)

Department of Advanced Biomedical Sciences, Pathology Unit, University of Naples Federico II, Naples, Italy.

Eugenia Bruzzese (E)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Gabriella Fabbrocini (G)

Department of Clinical Medicine and Surgery, Section of Dermatology, University of Naples Federico II, Naples, Italy.

Alfredo Guarino (A)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Maria Alessio (M)

Department of Translational Medical Sciences, Section of Pediatrics, University of Naples Federico II, Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH